4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis
-
16/05/2025, 07:03
-
ansa.it
0
Scopri altro
- oggi, 01:57
-
lastampa.it
-
-1
- 16/07/2025, 07:03
-
ansa.it
-
0
- 16/07/2025, 06:43
-
ansa.it
-
0
- 16/07/2025, 06:37
-
money.it
-
0
- 16/07/2025, 04:20
-
ansa.it
-
0
- 16/07/2025, 03:55
-
ansa.it
-
0
- 16/07/2025, 02:06
-
ansa.it
-
0
- 16/07/2025, 01:21
-
ansa.it
-
0
Nessun commento